Benzinga Virtual Events

Equity Or Debt: Which Is The Best Path For Cannabis Startups?

Are You Overlooking Critical Market Analysis In Your Cannabis Investments?

Whiskey's Best Kept Secret: Independent Bottlers Bring New Flavors To Market

Are You Overlooking Critical Market Analysis In Your Cannabis Investments?

Whiskey's Best Kept Secret: Independent Bottlers Bring New Flavors To Market

Capitalize On The Whiskey Renaissance: How Investors Can Tap Into Growing Trend

How Can You Profit From Whiskey, Startups, And Real Estate? Learn From Experts Throughout July

Capitalize On The Whiskey Renaissance: How Investors Can Tap Into Growing Trend

How Can You Profit From Whiskey, Startups, And Real Estate? Learn From Experts Throughout July

EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says

EXCLUSIVE: Half Of SPX Options Volume Now In Zero-Day Trades, Reveals Cboe Executive

Benzinga Virtual Events Recent News

EXCLUSIVE: 'On-Device AI Revolution Is Fundamental,' Says Qualcomm CFO

Qualcomm's CFO announced new on-device AI strategy at virtual event; efficient, cost-effective, and private, with new specialized chip for PCs.

EXCLUSIVE: Lithium Market Faces 'Daunting' Supply-Demand Challenge, Says Nevada Lithium CEO

"I have never seen a mismatch in supply and demand in my 30 years of experience following commodities," Stephen Rentschler says.

2024 Economic Outlook: Mixed Predictions, Rate Cuts, Growth Rebound

With the Road to Wealth virtual event just around the corner, investors and financial enthusiasts are eager to gain insight into the economic situation and its impact on financial planning.

EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads

Tema ETFs is redefining thematic investing, focusing on long-term structural trends & precision in security selection rather than chasing short-term fads.

Legal Shifts, Financial Waves: How Cannabis's Possible Reclassification Can Impact The Market

In a pivotal moment for the American cannabis sector, the U.S. Department of Health and Human Services (HHS) has proposed a reclassification of cannabis to the DEA. This could shift cannabis from its current Schedule I status, bringing potential upheaval in the perception and market dynamics of the plant.